Home > Balance Sheet > BIOCON

BIOCON
Capital Work in Progress

    Back to Balance Sheet
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
AD     Remove this Ad

BIOCON Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹4,102 Cr₹3,985 Cr₹2,588 Cr₹3,420 Cr₹2,254 Cr

What is the latest Capital Work in Progress ratio of BIOCON ?

The latest Capital Work in Progress ratio of BIOCON is ₹4,102 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹4,102 Cr
Mar2024₹3,985 Cr
Mar2023₹2,588 Cr
Mar2022₹3,420 Cr
Mar2021₹2,254 Cr

How is Capital Work in Progress of BIOCON Trending?

Years Capital Work in Progress % Change
Mar2025 ₹4,102 Cr
2.92
Mar2024 ₹3,985 Cr
54.02
Mar2023 ₹2,588 Cr
-24.35
Mar2022 ₹3,420 Cr
51.78
Mar2021 ₹2,254 Cr -

Compare Capital Work in Progress of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹58,490.2 Cr -1.8% -8.8% 5.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,647.0 Cr 0.1% -0.4% 0.6% Stock Analytics
DIVIS LABORATORIES ₹157,862.0 Cr -1.1% -7.1% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,846.0 Cr 0.2% -4.5% 30.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,720.0 Cr 0.2% -4% 6% Stock Analytics
CIPLA ₹98,795.9 Cr 0% -9.1% -18.5% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-1.8%

-8.8%

5.9%

SENSEX

-3.5%

-12.5%

-6.5%


You may also like the below Video Courses